Indian Journal of Endocrinology and Metabolism

ORIGINAL ARTICLE
Year
: 2013  |  Volume : 17  |  Issue : 8  |  Page : 453--457

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Eastern Saudi Arabia cohort of the A 1 chieve study


Faisal Hashim1, Muneeb Ahmed Yasser2, Oussama Khatib3 
1 Department of Internal Medicine, Endocrinology, Mana General Hospital, Jubail, Saudi Arabia
2 Department of Internal Medicine, Endocrinology, Mana General Hospital, Khobar, Saudi Arabia
3 Department of Endocrinology, Saad Specialist Hospital, Khobar, Saudi Arabia

Correspondence Address:
Faisal Hashim
Mana General Hospital, Jubail
Saudi Arabia

Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents. Materials and Methods: Data was collected at baseline, at 12 weeks and at 24 weeks. This short communication presents the results for patients enrolled from Eastern Saudi Arabia. Results: A total of 1040 patients were enrolled in the study. Four different insulin analogue regimens were used in the study. Study patients had started on or were switched to biphasic insulin aspart (n = 489), insulin detemir (n = 360), insulin aspart (n = 37), basal insulin plus insulin aspart (n = 96) and other insulin combinations (n = 57). At baseline glycaemic control was poor for both insulin naïve (mean HbA 1 c: 10.0%) and insulin user (mean HbA 1 c: 9.2%) groups. After 24 weeks of treatment, both the groups showed improvement in HbA 1 c (insulin naïve: −2.7%, insulin users: −1.7%). No major hypoglycaemic episodes were observed at 24 weeks. SADR was reported in 0.6% of insulin users. Conclusion: Starting or switching to insulin analogues was associated with improvement in glycaemic control with a low rate of hypoglycaemia.


How to cite this article:
Hashim F, Yasser MA, Khatib O. Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Eastern Saudi Arabia cohort of the A 1 chieve study.Indian J Endocr Metab 2013;17:453-457


How to cite this URL:
Hashim F, Yasser MA, Khatib O. Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Eastern Saudi Arabia cohort of the A 1 chieve study. Indian J Endocr Metab [serial online] 2013 [cited 2021 Mar 9 ];17:453-457
Available from: https://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=8;spage=453;epage=457;aulast=Hashim;type=0